Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Saturday, November 28, 2009, 8:25PM ET - U.S. Markets Closed. Dow Down 1.48% Nasdaq Down 1.73%
Orexigen Therapeutics, Inc. (OREX)On Nov 27: 6.90  Down 0.15 (2.13%)  
MORE ON OREX
Quotes
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
HereIncome Statement

Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
PERIOD ENDING31-Dec-0831-Dec-0731-Dec-06
Total Revenue88  88  88  
Cost of Revenue -   -   -  
Gross Profit88  88  88  
Operating Expenses
Research Development79,261  50,253  22,586  
Selling General and Administrative15,651  10,657  5,869  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss(94,824)(60,822)(28,367)
Income from Continuing Operations
Total Other Income/Expenses Net3,115  3,901  872  
Earnings Before Interest And Taxes(91,709)(56,921)(27,495)
Interest Expense1,531  846  8  
Income Before Tax(93,240)(57,767)(27,504)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(93,240)(57,767)(27,504)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income(93,240)(57,767)(27,504)
Preferred Stock And Other Adjustments -  (10)(13,890)
Net Income Applicable To Common Shares($93,240)($57,777)($41,394)

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Income Statement for Another Symbol: Symbol Lookup
Sector Analysis

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More